Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115084) titled 'Transnasal Dexmedetomidine for the Prevention and Treatment of Surgery-Related Stress Complications' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Lianyungang Second People's Hospital
Condition:
Preoperative Hypertension
Intervention:
Preoperative Hypertension Group (PH Group): Patients with a baseline blood pressure higher than 140/90 mmHg:All patients received intranasal dexmedetomidine (IN-DEX) at a dose of 1 µg/kg 30 minutes before anesthesia induction. The drug used was Dexmedetomidine Hydrochloride Injection (200 µg/2 ml) produced b...